Bradley J. Bolzon Ph.D., Director at CRISPR Therapeutics AG (CRSP), sold 269,824 shares at $150.99 ($39.4M) on 2021-02-19, disclosed to the SEC on 2021-02-23.
Open-market sale of $39.4M CRSP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 6,018 | $0 | 0.0% |
| 2 | $147.79 | 78,200 | $11.6M | 29.3% |
| 3 | $149.24 | 23,276 | $3.5M | 8.8% |
| 4 | $149.24 | 23,276 | $3.5M | 8.8% |
| 5 | $150.10 | 38,132 | $5.7M | 14.5% |
| 6 | $150.10 | 38,132 |
| $5.7M |
| 14.5% |
| 7 | $150.99 | 27,932 | $4.2M | 10.7% |
| 8 | $150.99 | 27,932 | $4.2M | 10.7% |
| 9 | $151.82 | 3,463 | $526K | 1.3% |
| 10 | $151.82 | 3,463 | $526K | 1.3% |
| Total | $146.16 avg | 269,824 | $39.4M | 100% |
| Filing → |
| CRSP | SELL | 2021-06-30 | $14.1M | — | Filing → |
| CRSP | SELL | 2021-06-30 | $9.2M | — | Filing → |
| CRSP | SELL | 2021-06-15 | $2.3M | — | Filing → |